nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—CES2—Phase I biotransformations, non P450—ESD—ocular cancer	0.33	0.33	CbGpPWpGaD
Dabigatran etexilate—CES1—Phase I biotransformations, non P450—ESD—ocular cancer	0.195	0.195	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN2C—ocular cancer	0.0208	0.0208	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—E2F5—ocular cancer	0.0173	0.0173	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—E2F4—ocular cancer	0.017	0.017	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—MYBL2—ocular cancer	0.017	0.017	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—RBL1—ocular cancer	0.0167	0.0167	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—E2F2—ocular cancer	0.0167	0.0167	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—RBL2—ocular cancer	0.0153	0.0153	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—E2F3—ocular cancer	0.0144	0.0144	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—RBBP4—ocular cancer	0.0144	0.0144	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDC25A—ocular cancer	0.0137	0.0137	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—TFDP1—ocular cancer	0.0134	0.0134	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN2C—ocular cancer	0.0123	0.0123	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CCND3—ocular cancer	0.0122	0.0122	CbGpPWpGaD
Dabigatran etexilate—F2—PAR4-mediated thrombin signaling events—GNA11—ocular cancer	0.012	0.012	CbGpPWpGaD
Dabigatran etexilate—F2—PAR4-mediated thrombin signaling events—GNAQ—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—E2F5—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—E2F4—ocular cancer	0.01	0.01	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—MYBL2—ocular cancer	0.01	0.01	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—E2F2—ocular cancer	0.00982	0.00982	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—RBL1—ocular cancer	0.00982	0.00982	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—RBL2—ocular cancer	0.00902	0.00902	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—E2F3—ocular cancer	0.00851	0.00851	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—RBBP4—ocular cancer	0.00851	0.00851	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDC25A—ocular cancer	0.0081	0.0081	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—TFDP1—ocular cancer	0.00792	0.00792	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—HDAC1—ocular cancer	0.0078	0.0078	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CCND3—ocular cancer	0.00718	0.00718	CbGpPWpGaD
Dabigatran etexilate—F2—Thrombin signalling through proteinase activated receptors (PARs)—GNA11—ocular cancer	0.00654	0.00654	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—E2F1—ocular cancer	0.00642	0.00642	CbGpPWpGaD
Dabigatran etexilate—F2—Thrombin signalling through proteinase activated receptors (PARs)—GNAQ—ocular cancer	0.00608	0.00608	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDK2—ocular cancer	0.00554	0.00554	CbGpPWpGaD
Dabigatran etexilate—F2—PAR1-mediated thrombin signaling events—GNA11—ocular cancer	0.00516	0.00516	CbGpPWpGaD
Dabigatran etexilate—F2—PAR1-mediated thrombin signaling events—GNAQ—ocular cancer	0.0048	0.0048	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—HDAC1—ocular cancer	0.0046	0.0046	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—RB1—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—TP53—ocular cancer	0.0042	0.0042	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—E2F1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN1B—ocular cancer	0.00354	0.00354	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPAR Alpha Pathway—CDK4—ocular cancer	0.00329	0.00329	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN1A—ocular cancer	0.00327	0.00327	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDK2—ocular cancer	0.00326	0.00326	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—EP300—ocular cancer	0.00311	0.00311	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—MYC—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—RB1—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—TP53—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPAR Alpha Pathway—CCND1—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN1B—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN1A—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PSPH—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—EP300—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPAR Alpha Pathway—MYC—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—MYC—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GNA11—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—TGFB1—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GNAQ—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—EIF1AX—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet Aggregation (Plug Formation)—AKT1—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—RPL39—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000993	0.000993	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000974	0.000974	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.000923	0.000923	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—TGFB1—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TP53—ocular cancer	0.000876	0.000876	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PSPH—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—GNA11—ocular cancer	0.000718	0.000718	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PSPH—ocular cancer	0.000701	0.000701	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—GNAQ—ocular cancer	0.000667	0.000667	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—EP300—ocular cancer	0.000616	0.000616	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000615	0.000615	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—HRAS—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000603	0.000603	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—HDAC1—ocular cancer	0.000602	0.000602	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GNA11—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GNAQ—ocular cancer	0.000554	0.000554	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—ocular cancer	0.000526	0.000526	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SAG—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00047	0.00047	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNA11—ocular cancer	0.000454	0.000454	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—E2F5—ocular cancer	0.000453	0.000453	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—E2F4—ocular cancer	0.000444	0.000444	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RBL1—ocular cancer	0.000436	0.000436	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CDK2—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000425	0.000425	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNAQ—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNA11—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000409	0.000409	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000405	0.000405	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNAQ—ocular cancer	0.000383	0.000383	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—E2F3—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000375	0.000375	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TFDP1—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PSPH—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAML2—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNA11—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNAQ—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNA11—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—EP300—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNAQ—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNA11—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNAQ—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HDAC1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—EP300—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN2B—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—E2F1—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—HRAS—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MDM2—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNA11—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HRAS—ocular cancer	9.42e-05	9.42e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNAQ—ocular cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN1B—ocular cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—ocular cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—EP300—ocular cancer	9.07e-05	9.07e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCND1—ocular cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN1A—ocular cancer	8.55e-05	8.55e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—ocular cancer	8.32e-05	8.32e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EP300—ocular cancer	8.13e-05	8.13e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—EP300—ocular cancer	7.37e-05	7.37e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MYC—ocular cancer	7.09e-05	7.09e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—ocular cancer	7.07e-05	7.07e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—ocular cancer	5.82e-05	5.82e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HRAS—ocular cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—ocular cancer	5.48e-05	5.48e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—ocular cancer	4.91e-05	4.91e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—ocular cancer	4.45e-05	4.45e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—EP300—ocular cancer	3.38e-05	3.38e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—ocular cancer	2.04e-05	2.04e-05	CbGpPWpGaD
